B
BrainsWay Ltd. (BWAY)
NGM – Real vaqt narxi. Valyuta: USD
14.48
-0.06 (-0.41%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
14.48
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:43 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NGM – Real vaqt narxi. Valyuta: USD
14.48
-0.06 (-0.41%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
14.48
0.00 (0.00%)
Bozordan keyin: Jun 26, 2026, 4:43 PM EDT
BrainsWay Ltd. Qo'shma Shtatlar va xalqaro miqyosda ruhiy kasalliklar uchun invaziv bo'lmagan neyrostimulyatsiya muolajalarini ishlab chiqadi va sotadi. U chuqur transkranial magnit stimulyatsiya platformasi texnologiyasini katta depressiya buzilishi, xavotirli va keksalik depressiyasi, obsesif-kompulsiv buzilishi, chekishga qaramlik, bipolyar buzilishi, post-travmatik stress buzilishi, shizofreniya, Altsgeymer kasalligi, avizm, surunkali og'riq, ko'p skleroz, insultdan keyingi reabilitatsiya va Parkinson kasalliklarini davolash uchun taklif etadi. Kompaniya psixiatriya sohasidagi shifokorlar, shifoxonalar va tibbiyot markazlariga xizmat ko'rsatadi. Kompaniya 2003-yilda tashkil etilgan bo'lib, shtab-kvartirasi Isroilning Quddus shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Colleen Hanlon Ph.D. | Vice President of Medical Affairs |
| Dr. David Zacut M.D. | Co-Founder & Vice-Chairman |
| Dr. Yiftach Roth Ph.D. | Founder & Chief Scientific Officer |
| Mr. Dor Hagai | Vice President of Operations |
| Mr. Gilead Moiseyev Ph.D. | Chief Technology Officer |
| Mr. Hadar Levy | Chief Executive Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-22 | 6-K | f6k_062126.htm |
| 2026-06-09 | 6-K | f6k_060826.htm |
| 2026-05-18 | 6-K | f6k_051726.htm |
| 2026-05-13 | 6-K | f6k_051226.htm |
| 2026-04-20 | S-8 POS | fs8pos_041626.htm |
| 2026-04-20 | S-8 | fs8_041626.htm |
| 2026-04-20 | 20-F | f20f_032726.htm |
| 2026-04-15 | 6-K | f6k_041426.htm |
| 2026-03-26 | 6-K | f6k_032526.htm |
| 2026-03-19 | 6-K | f6k_031926.htm |
| Mr. Ido Marom | Chief Financial Officer |
| Mr. Menachem C. Klein Esq. | VP, General Counsel & Corporate Secretary |
| Mr. Michael Cohen | Vice President of US Sales |
| Prof. Abraham Zangen Ph.D. | Co-Founder, Member of Scientific Advisory Board & Director |